Filter By Industry
Filter By Tag

Newsroom

Corporate Ads Press releases

291 - 291 of 291 Press Releases

Substantial Funding, Debt Resolution, HOPE Dividend, Successful Clinical Trial Towards Accelerated Drug Approval for Bipolar Depression: Nasdaq: NRXP
Aug 14, 2024
HOPE Therapeutic Subsidiary Focused on Developing a Best-in-Class Network of Clinics for Patients with Suicidal Depression and Related Disorders. HOPE is Planned to be Spun Out as a Separate Company to be Owned by NRXP Shareholders, and New Investors.


Page: Prev 26 27 28 29 30
Corporate Ads RSS Feed